Medication info
Yuyou Telmisartan Plus Tablet 80/12.5 Milligrams

Yuyou Telmisartan Plus Tablet 80/12.5 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Yuyou Pharmaceutical Co., Ltd.
Appearance
Oval-shaped tablet consisting of two layers in white/pink, with possible pink specks on the white layer.
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201000888 · Notified 2010.01.27 · Insurance code 644501710

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the doses of the individual components be adjusted separately according to the patient's needs. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this medicine should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dosage adjustment is required.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Yuyou Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension and is administered as an additional treatment option to patients whose blood pressure is not adequately controlled with telmisartan alone. It helps to effectively manage blood pressure, thereby assisting in the prevention of complications related to hypertension.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the doses of the individual components be adjusted separately according to the patient's needs. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this medicine should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dosage adjustment is required.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This drug can cause severe harm to the fetus during pregnancy, particularly during the second and third trimesters, so it should be avoided in pregnant individuals. Patients with allergies to any of the components or additives in this drug, hypersensitivity to sulfonamide drugs, pregnant or nursing mothers should not take this drug. It should not be administered to patients with severe liver or kidney impairment, biliary obstructive disease, acute nephritis, anuria, or electrolyte imbalance. Elderly patients or those with elevated serum potassium levels, liver function issues, or heart disease should use caution when taking this drug, and regular skin examinations are recommended for those at risk for skin cancer. This drug has blood pressure-lowering effects, which may cause dizziness, hypotension, or fainting; caution is required when driving or operating machinery. During treatment, regular checks of blood electrolyte levels and kidney function should be conducted to detect abnormalities early. This medication may interact with other blood pressure medications, diuretics, lithium, certain antiarrhythmics, and non-steroidal anti-inflammatory drugs, so it is essential to inform your doctor or pharmacist about any other medications currently being taken. In case of overdose, symptoms may include hypotension, cardiac rhythm abnormalities, electrolyte imbalances, and dehydration, so immediate medical assistance should be sought. This drug should not be used in children since its safety and efficacy have not been established.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 123 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • liver disorder
  • angioedema
  • erythema
  • pruritus
  • rash
  • sweating
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hypersensitivity
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • cough
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic dermal eruption
  • bone pain
  • renal dysfunction
  • weakness
  • influenza-like illness
  • increased blood creatinine
  • increased blood uric acid
  • elevated liver enzymes
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • aplastic anemia
  • hypomagnesemia
  • hyperlipidemia
  • decreased appetite
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • headache
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • choroidal effusion
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • jaundice
  • bile stasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal dysfunction
  • weakness
  • fever
  • dizziness
  • itching
  • myalgia
  • headache
  • feeling of floatation
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • gastritis
  • fatigue
  • weight loss
  • proteinuria
  • lip and hand tremors
  • sensory hyperesthesia
  • vision loss
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to air and moisture, so it must be stored in a tightly closed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This way, the effectiveness of the drug can be preserved for a long time.

Appearance and packaging

Appearance

Oval-shaped tablet consisting of two layers in white/pink, with possible pink specks on the white layer.

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.